Abstract
Background: A recent meta-analysis of nine cohort studies in youths reported that baseline ever e-cigarette use strongly predicted cigarette smoking initiation in the next 6-18 months, with an adjusted odds ratio (OR) of 3.62 (95% confidence interval 2.42-5.41). A recent e-cigarette review agreed there was substantial evidence for this “gateway effect”. As the number of confounders considered in the studies was limited we investigated whether the effect might have resulted from inadequate adjustment, using Waves 1 and 2 of the US PATH study. Methods: Our main analyses considered Wave 1 never cigarette smokers who, at Wave 2, had data on smoking initiation.We constructed a propensity score for ever e-cigarette use from Wave 1 variables, using this to predict ever cigarette smoking. Sensitivity analyses accounted for other tobacco product use, linked current e-cigarette use to subsequent current smoking, or used propensity scores for ever smoking or ever tobacco product use as predictors. We also considered predictors using data from both waves, attempting to reduce residual confounding from misclassified responses. Results: Adjustment for propensity dramatically reduced the unadjusted OR of 5.70 (4.33-7.50) to 2.48 (1.85-3.31), 2.47 (1.79-3.42) or 1.85 (1.35-2.53), whether adjustment was made as quintiles, as a continuous variable or for the individual variables. Additional adjustment for other tobacco products reduced this last OR to 1.59 (1.14-2.20). Sensitivity analyses confirmed adjustment removed most of the gateway effect. Control for residual confounding also reduced the association. Conclusions: We found that confounding is a major factor, explaining most of the observed gateway effect. However, our analyses are limited by small numbers of new smokers considered and the possibility of over-adjustment if taking up e-cigarettes affects some predictor variables. Further analyses are intended using Wave 3 data to try to minimize these problems, and clarify the extent of any true gateway effect.
Funder
Philip Morris Products SA
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献